Market Research Logo

Elekta AB (EKTA B) - Financial and Strategic SWOT Analysis Review

Elekta AB (EKTA B) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Elekta AB (Elekta) is a medical technology company that offers image guided and stereotactic clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. Its major products include Gamma knife and Extend system; stereotactic system; fully integrated stereotactic radiation therapy system; system for volumetric arc modulated therapy (VMAT); image guided radiation therapy (IGRT) systems; advanced digital treatment systems; treatment planning systems; electronic brachy therapy for skin cancer; and automated remote after loading platform. It also offers oncology information systems for radiation oncology and medical oncology, treatment planning software, cancer registry and soft tissue visualization software, among others. Elekta products find applications the treatment of cancer using radio therapy and in diagnosis and treatment of brain disorders in hospitals, academic institutions, and specialist and satellite clinics throughout the world. The company operates in North America, Europe, the Middle East, Africa and Asia-Pacific. Elekta is headquartered in Stockholm, Sweden.

Elekta AB Key Recent Developments

Aug 03,2017: C-RAD to supply advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna
Jul 14,2017: Steven Wort appointed as Elekta’s Chief Operating Officer
Jun 26,2017: Elekta Chooses Brainlab to Distribute Stereotactic Neurosurgical Solutions Within Selected Markets in Europe
Jun 22,2017: Equicare Health and Elekta announce Vendor Interoperability Program partnership
Jun 20,2017: Alliance Cancer Care to Upgrade Cancer Care in Southeastern U.S. with Elekta Solutions

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company 5
Elekta AB - Key Facts 5
Elekta AB - Key Employees 6
Elekta AB - Key Employee Biographies 7
Elekta AB - Major Products and Services 8
Elekta AB - History 11
Elekta AB - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 15
Elekta AB - Business Description 15
Elekta AB - SWOT Analysis 16
SWOT Analysis - Overview 16
Elekta AB - Strengths 16
Elekta AB - Weaknesses 17
Elekta AB - Opportunities 18
Elekta AB - Threats 19
Elekta AB - Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios - Capital Market Ratios 21
Financial Ratios - Annual Ratios 22
Performance Chart 25
Financial Performance 25
Financial Ratios - Interim Ratios 26
Financial Ratios - Ratio Charts 27
Section 4 – Company’s Lifesciences Financial Deals and Alliances 28
Elekta AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 28
Elekta AB, Medical Equipment, Deals By Type, 2011 to YTD 2017 29
Elekta AB, Recent Deals Summary 30
Section 5 – Company’s Recent Developments 31
Jul 14, 2017: Steven Wort appointed as Elekta’s Chief Operating Officer 31
Jul 13, 2017: Elekta to Implement Critical Manufacturing for Global Production Excellence 32
Jun 26, 2017: Elekta Chooses Brainlab to Distribute Stereotactic Neurosurgical Solutions Within Selected Markets in Europe 33
Jun 22, 2017: Equicare Health and Elekta announce Vendor Interoperability Program partnership 34
Jun 20, 2017: Alliance Cancer Care to Upgrade Cancer Care in Southeastern U.S. with Elekta Solutions 35
Jun 01, 2017: Elekta: Year-end report May-April 2016/17 36
Jun 01, 2017: Peter Gaccione joins Elekta’s Executive Management as head of North America 38
May 26, 2017: Elekta Radiosurgery Solutions Highlighted at International Stereotactic Radiosurgery Society Congress 39
May 10, 2017: Elekta appoints Gustaf Salford as Chief Financial Officer 40
May 02, 2017: Elekta to Showcase the Latest in Stereotactic Solutions at ESTRO 36 41
Section 6 – Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Tables
Elekta AB, Key Facts 5
Elekta AB, Key Employees 6
Elekta AB, Key Employee Biographies 7
Elekta AB, Major Products and Services 8
Elekta AB, History 11
Elekta AB, Other Locations 12
Elekta AB, Subsidiaries 12
Elekta AB, Key Competitors 20
Elekta AB, Ratios based on current share price 21
Elekta AB, Annual Ratios 22
Elekta AB, Annual Ratios (Cont...1) 23
Elekta AB, Annual Ratios (Cont...2) 24
Elekta AB, Interim Ratios 26
Elekta AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 28
Elekta AB, Medical Equipment, Deals By Type, 2011 to YTD 2017 29
Elekta AB, Recent Deals Summary 30
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 45
Efficiency Ratios 45
List of Figures
Elekta AB, Performance Chart (2013 - 2017) 25
Elekta AB, Ratio Charts 27
Elekta AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 28
Elekta AB, Medical Equipment, Deals by Type, 2011 to YTD 2017 29

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report